Breast cancer and hormone-replacement therapy: the Million Women Study

Sarah Gray
Lancet (London, England) · 2003 · vol. 362(9392) , pp. 1332 · doi:10.1016/s0140-6736(03)14598-9 · PMID:14575993 · W3144959505
Other OA: bronze CC0 ⤵ 1 in-corpus citation
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-10 ⓘ

The Million Women Study investigated the association between hormone replacement therapy and breast cancer risk, finding an increased risk with current use.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Breast Neoplasms Hormone Replacement Therapy Breast Neoplasms Breast Neoplasms Estrogen Replacement Therapy Estrogen Replacement Therapy Estrogens, Conjugated (USP) Estrogens, Conjugated (USP) Family Practice Female Hormone Replacement Therapy Hormone Replacement Therapy Humans Menopause Menopause Women's Health

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

References (2)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:02:06.159351+00:00
License: CC0 · commercial use OK